Tumor suppressor CD99 is downregulated in plasma cell neoplasms lacking CCND1 translocation and distinguishes neoplastic from normal plasma cells and B cell lymphomas with plasmacytic differentiation from primary plasma cell neoplasms

CD99(MIC2) is a widely expressed cell surface glycoprotein and functions as a tumor suppressor involved in downregulation of SRC family of tyrosine kinase. CD99 expression is tightly regulated through B cell development. The principal aims of this study were to investigate the clinical utility of CD...

Descripción completa

Detalles Bibliográficos
Autores principales: Gao, Qi, Yellapantula, Venkata, Fenelus, Maly, Pichardo, Janine, Wang, Lu, Landgren, Ola, Dogan, Ahmet, Roshal, Mikhail
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5998376/
https://www.ncbi.nlm.nih.gov/pubmed/29403080
http://dx.doi.org/10.1038/s41379-018-0011-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5998376/
https://www.ncbi.nlm.nih.gov/pubmed/29403080
http://dx.doi.org/10.1038/s41379-018-0011-0

Ejemplares similares